Sonic Fund II L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-30 4:11 pm Sale |
2022-12-27 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 463,143 4.600% |
-200,000 (-30.16%) |
Filing |
| 2021-04-16 3:11 pm Unchanged |
2021-04-15 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 663,143 6.800% |
0 (Unchanged) |
Filing |
| 2021-04-09 4:54 pm Purchase |
2021-03-24 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 663,143 6.800% |
50,000 (+8.15%) |
Filing |
| 2021-03-18 2:21 pm Purchase |
2021-03-15 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 613,143 6.300% |
91,528 (+17.55%) |
Filing |
| 2021-02-16 3:46 pm Purchase |
2020-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 521,615 5.400% |
96,887 (+22.81%) |
Filing |
| 2020-08-20 2:21 pm Purchase |
2020-08-18 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 424,728 4.400% |
45,172 (+11.90%) |
Filing |